CLINICAL IMMUNOLOGY
Scope & Guideline
Advancing the Frontiers of Immunological Science
Introduction
Aims and Scopes
- Autoimmunity and Immune Dysregulation:
Research on the mechanisms underlying autoimmune diseases, including systemic lupus erythematosus, rheumatoid arthritis, and other immune dysregulatory disorders. This includes studies on the genetic, epigenetic, and environmental factors influencing autoimmunity. - Primary Immunodeficiencies:
Exploration of the genetic basis, clinical presentations, and therapeutic approaches for various inborn errors of immunity. This includes studies on novel mutations, their implications for diagnosis and treatment, and the development of clinical guidelines. - Translational Immunology:
Integration of basic immunological research with clinical applications, including the development of novel immunotherapies, vaccine responses, and therapeutic strategies for managing immune-related diseases. - Immuno-oncology:
Investigation of the immune system's role in cancer, including the mechanisms of immune evasion by tumors, the development of immunotherapies, and the identification of biomarkers predictive of treatment response. - Infectious Diseases and Immunity:
Studies focusing on the immune response to infectious agents, including the impact of viral infections (like SARS-CoV-2) on immune function and the role of vaccination in enhancing immunity. - Immunometabolism:
Research into the metabolic pathways that influence immune cell function and the implications of metabolic dysregulation in autoimmune and inflammatory diseases. - Biomarkers and Diagnostics:
Development and validation of biomarkers for disease activity, prognosis, and treatment response in various immunological disorders. - Clinical Trials and Therapeutics:
Reporting on clinical trials investigating new therapeutic agents, including monoclonal antibodies, small molecules, and cellular therapies aimed at modulating immune responses.
Trending and Emerging
- COVID-19 and Immune Response:
The pandemic has spurred a significant increase in research focused on the immune response to SARS-CoV-2, including studies on vaccine efficacy, post-viral syndromes, and the role of the immune system in disease severity. - Precision Medicine in Immunology:
An emerging focus on personalized approaches to immunotherapy and treatment for autoimmune diseases, with an emphasis on genetic and biomarker-based stratification of patients. - Long COVID and Immune Dysfunction:
Investigations into the long-term immune consequences of COVID-19, including persistent immune dysregulation and its clinical implications, have gained traction in recent publications. - Neuroimmunology:
Increased exploration of the interplay between the nervous system and immune responses, particularly in the context of autoimmune neurological disorders and neurodegenerative diseases. - Microbiome and Immunity:
Research on the relationship between the microbiome and immune system function is emerging, with studies exploring how microbiota composition influences autoimmune diseases and treatment responses. - Immunotherapy Advancements:
A growing trend in the exploration of novel immunotherapies, including bispecific antibodies, CAR-T cell therapies, and other innovative strategies targeting immune checkpoints.
Declining or Waning
- Traditional Vaccine Research:
Research focused solely on the efficacy and safety of traditional vaccines has decreased, likely due to the rapid development and deployment of mRNA vaccines and other novel platforms that have overshadowed conventional approaches. - Single Disease Focus Studies:
There has been a noticeable reduction in studies that concentrate exclusively on single disease models without considering the broader immunological context or comorbidities, reflecting a shift towards more integrative and holistic research approaches. - Basic Immunology Without Clinical Relevance:
Papers that present basic immunological findings without clear clinical implications have become less frequent, as the journal increasingly prioritizes studies with direct applications to patient care and treatment strategies. - Historical Perspectives on Immunology:
The publication of historical reviews or retrospective studies on immunology has waned, likely as the field moves towards more contemporary and forward-looking research that addresses current challenges.
Similar Journals
CLINICAL AND EXPERIMENTAL IMMUNOLOGY
Shaping the Future of Immunological ScienceClinical and Experimental Immunology, published by Oxford University Press, is a premier journal that has been a cornerstone in the field of immunology since its inception in 1966. With an ISSN of 0009-9104 and an E-ISSN of 1365-2249, this journal holds a significant position in academic research, currently ranking in the Q2 category for both Immunology and Allergy (2023). Its impactful contributions are reflected in its Scopus rankings, where it stands at Rank #63 out of 233 in Immunology and Allergy, placing it in the 73rd percentile, and Rank #73 out of 236 in Immunology and Microbiology. Researchers, healthcare professionals, and students will find this journal an invaluable resource for cutting-edge studies, reviews, and clinical advancements in the ever-evolving domain of immunology. While the publication does not offer open-access options, it remains a pivotal platform for disseminating knowledge that impacts both clinical practice and experimental research.
JOURNAL OF IMMUNOLOGY
Connecting Researchers for a Healthier TomorrowWelcome to the JOURNAL OF IMMUNOLOGY, a prestigious publication associated with the American Association of Immunologists and dedicated to advancing the field of immunology. With a rich history dating back to 1945, this journal is renowned for its high-impact research, evident in its notable 2023 Q1 rankings in both Immunology and Allergy, as well as its strong positions in Scopus rankings—Rank #68 in Immunology and Allergy and Rank #79 in Immunology and Microbiology. Although it operates on a subscription basis, its commitment to publishing cutting-edge studies ensures that it remains a vital resource for scientists, healthcare professionals, and students alike. As the journal continues to pave the way for innovative research and breakthroughs in immunological science, it facilitates a platform for dialogue and discovery among researchers and practitioners across the globe.
Cellular & Molecular Immunology
Connecting Research, Practice, and Progress in ImmunologyCellular & Molecular Immunology is a prestigious peer-reviewed journal published by the CHIN SOCIETY IMMUNOLOGY. As a leading journal in the fields of immunology and infectious diseases, it proudly holds a Q1 designation across multiple categories, including Immunology, Allergy, and Medicine (Miscellaneous), reflecting its commitment to excellence and impactful research. With an ISSN of 1672-7681 and an E-ISSN of 2042-0226, the journal has been essential reading since its inception in 2004, continuously gathering insights from cutting-edge studies. It ranks impressively within Scopus, with positions in the 7th, 8th, and 9th percentile in relevant categories, establishing it as a cornerstone for researchers, clinicians, and students alike. The journal offers an extensive range of original research articles, reviews, and clinical studies, ensuring that readers stay at the forefront of immunological discovery. Whether you are interested in basic immunology, infectious diseases, or evolving therapies, Cellular & Molecular Immunology serves as an invaluable resource for advancing your knowledge and engagement in this dynamic field.
INTERNATIONAL REVIEWS OF IMMUNOLOGY
Unlocking Insights in Immunology and AllergyINTERNATIONAL REVIEWS OF IMMUNOLOGY, published by Taylor & Francis Inc, is a leading academic journal that has been a cornerstone of immunological research since its inception in 1986. With an impressive impact factor and ranked in the top quartiles of its field (Q2 in both Immunology and Allergy), this journal offers a critical platform for the dissemination of influential findings and advancements within immunology. Spanning a diverse array of topics, from basic immune mechanisms to clinical applications, it aims to support the global scientific community in enhancing immunological understanding and therapeutic interventions. Researchers and professionals alike benefit from insights provided by renowned contributors, ensuring that the journal remains relevant in a rapidly evolving field. Directly accessible through subscription or institutional access, INTERNATIONAL REVIEWS OF IMMUNOLOGY is committed to fostering collaboration and innovation, making it an essential resource for anyone involved in immunological research and practice.
GENES AND IMMUNITY
Pioneering Insights into Genetic Influences on ImmunityGENES AND IMMUNITY, published by SpringerNature, is a leading scholarly journal dedicated to advancing the field of genetics and immunology. With an impressive impact factor and a distinguished ranking in the Q1 quartile of both Genetics and Immunology disciplines for 2023, this journal serves as a pivotal platform for researchers and professionals looking to explore the intricate relationships between genetic factors and immune responses. Established in 1999 and continuously published until 2024, it features high-quality peer-reviewed research articles, reviews, and commentary that address critical issues and recent advancements in the field. The journal adheres to rigorous academic standards, evidenced by its strong Scopus rankings, making it a valuable resource for students, researchers, and practitioners alike who are seeking to deepen their understanding of genetics' role in immunity. For those looking to keep abreast of cutting-edge insights, GENES AND IMMUNITY is an essential read.
IMMUNOLOGY LETTERS
Elevating Immunology: Where Research Meets PracticeIMMUOLOGY LETTERS, published by Elsevier, is a distinguished journal in the field of immunology, focusing on the latest advancements and findings that significantly influence immunological research and clinical applications. Established in 1979, the journal has evolved to cater to a global readership, featuring high-quality peer-reviewed articles across a diverse spectrum of topics related to immunity and allergic responses. With an impressive Q2 category ranking in both Immunology and Allergy as of 2023, it holds a strong position within the scientific community, evidenced by its commendable Scopus rankings (Rank #71/233 in Medicine - Immunology and Allergy and Rank #85/236 in Immunology and Microbiology - Immunology). While primarily subscription-based, the journal aims to foster knowledge dissemination that encourages collaboration among researchers and practitioners alike, making significant contributions to the understanding of immune mechanisms. The journal is integral for educators, students, and professionals aiming to stay abreast of current trends and breakthroughs in the immune system's intricate functions.
HUMAN IMMUNOLOGY
Advancing the Frontiers of Immune ResearchHUMAN IMMUNOLOGY, published by Elsevier Science Inc, serves as a critical platform for disseminating research in the fields of immunology and allergy, as well as various aspects of miscellaneous medicine since its inception in 1980. With an ISSN of 0198-8859 and E-ISSN 1879-1166, this journal is pivotal for researchers and practitioners looking to advance their understanding of human immune responses and related conditions. The journal currently holds a respectable position within its field, as highlighted by its 2023 Scopus ranks—#114/233 in Immunology and Allergy and #132/236 in Immunology and Microbiology. Moreover, it maintains a Q2 quartile ranking in both Immunology and Allergy and miscellaneous Medicine, underscoring its influence and reach within the scientific community. Although it does not currently offer Open Access options, HUMAN IMMUNOLOGY remains dedicated to providing valuable insights and fostering academic discourse within its discipline, characterized by a rigorous peer-review process and a focus on innovative research trajectories.
IMMUNOBIOLOGY
Connecting researchers to revolutionize the understanding of immune systems.IMMUNOBIOLOGY is a prestigious academic journal published by Elsevier GmbH that significantly contributes to the fields of hematology and immunology. With its ISSN 0171-2985 and E-ISSN 1878-3279, this journal has been disseminating impactful research since 1979, positioning itself at the forefront of immunological and hematological advances. The journal holds a commendable ranking of Q2 in Hematology and Q3 in both Immunology and Immunology and Allergy, indicating its relevance and influence within the scientific community, as reflected by its Scopus rankings. Although IMMUNOBIOLOGY operates under a subscription model, it remains dedicated to expanding knowledge across disciplines, fostering innovative research, and facilitating connections among researchers, professionals, and students. Situated in Munich, Germany, this journal is continually evolving and aims to remain an essential resource for the latest discoveries and insights in the realms of immunity and blood disorders, ultimately enhancing our understanding of complex biological systems.
Immune Network
Empowering Researchers to Shape the Future of ImmunologyImmune Network is a prestigious journal dedicated to disseminating high-quality research in the field of immunology, infectious diseases, and allergy, under the esteemed KOREA ASSOCIATION OF IMMUNOLOGISTS. Founded in 2016, this journal has quickly ascended to a top-tier publication, achieving Q1 rankings in 2023 in multiple relevant categories, including Immunology, Allergy, and Infectious Diseases. With a strong emphasis on innovation and interdisciplinary research, Immune Network appeals to a diverse audience of researchers, professionals, and students keen on advancing the understanding of immune responses and disease mechanisms. However, it is crucial to note that the journal operates under a subscription model without open-access provisions. Its impact factor further solidifies its reputation, reflecting the significant influence of the articles published. Located in South Korea, the journal serves as a global platform for sharing revolutionary insights and fostering collaborations within the immunology community.
JOURNAL OF CLINICAL IMMUNOLOGY
Connecting Researchers to the Heart of ImmunologyJOURNAL OF CLINICAL IMMUNOLOGY, published by SPRINGER/PLENUM PUBLISHERS, is a leading journal in the field of immunology, with an impressive standing as reflected in its Q1 ranking in both Immunology and Immunology and Allergy for 2023. With a history of publication dating back to 1981 and an E-ISSN of 1573-2592, this journal aims to disseminate cutting-edge research on diagnostic methods, therapeutic strategies, and understanding the mechanisms underlying immune responses. Its significant impact is underscored by its Scopus rankings, where it is placed in the top 15% of journals covering immunology and microbiology. The journal does not currently operate under an Open Access model, yet offers a robust platform for sharing essential findings that contribute to advancements in clinical immunology. As a resource for researchers, professionals, and students, the JOURNAL OF CLINICAL IMMUNOLOGY is pivotal in fostering dialogue and disseminating knowledge that enhances our understanding of immune-related diseases.